MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
22.46
-0.44 (-1.92%)
Nov 1, 2024, 4:00 PM EDT - Market closed
MBX Biosciences Employees
MBX Biosciences had 27 employees as of December 31, 2023.
Employees
27
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,748,148
Market Cap
749.80M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 27 | - | - |
Related Stocks
Company Name | Employees |
---|---|
InnovAge Holding | 2,350 |
Pacira BioSciences | 712 |
Standard BioTools | 539 |
Sana Biotechnology | 328 |
EyePoint Pharmaceuticals | 121 |
Arbutus Biopharma | 73 |
Annexon | 71 |
Nuvation Bio | 51 |
MBX News
- 4 days ago - MBX Biosciences to Participate in Upcoming November Investor Conferences - GlobeNewsWire
- 4 weeks ago - MBX Biosciences Presents MBX 2109 Phase 2 Avail™ Hypoparathyroidism Trial Rationale and Design at the ASBMR 2024 Annual Meeting - GlobeNewsWire
- 6 weeks ago - MBX Biosciences Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 6 weeks ago - U.S. IPO Weekly Recap: 3 Biotechs Lead Active September IPO Market - Seeking Alpha
- 7 weeks ago - MBX Biosciences shares surge 44% in blockbuster Nasdaq debut - Reuters
- 7 weeks ago - MBX Biosciences raises $163.2 mln in US IPO - Reuters
- 7 weeks ago - MBX Biosciences Announces Pricing of Initial Public Offering - GlobeNewsWire
- 7 weeks ago - MBX Biosciences Announces Launch of Initial Public Offering - GLOBE NEWSWIRE